The Advisor Pro Direct Study

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 1, 2020

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

DreaMed Advisor Pro

Insulin pump settings (i.e, basal plan, correction factor, carbohydrate ratio and insulin activity time) will be adjusted using the DreaMed Advisor Pro and sent directly to the patient

OTHER

Medical guided recommendation

Insulin pump settings (i.e, basal plan, correction factor, carbohydrate ratio and insulin activity time) will be adjusted by the medical team according to standard of care

Trial Locations (1)

49202

Schnider Children's medical center, Petah Tikva

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

DreaMed

INDUSTRY

lead

Rabin Medical Center

OTHER

NCT03774069 - The Advisor Pro Direct Study | Biotech Hunter | Biotech Hunter